603858 步长制药
交易中 02-10 14:07:09
资讯
新帖
简况
步长制药84岁创始人被限高，赵氏家族资本版图扩张风波不断
蓝鲸财经 · 02-09 19:26
步长制药84岁创始人被限高，赵氏家族资本版图扩张风波不断
每周股票复盘：步长制药（603858）首次回购股份217.6万股
证券之星 · 02-08 02:15
每周股票复盘：步长制药（603858）首次回购股份217.6万股
步长制药（603858）披露拟放弃优先受让控股子公司股权暨关联交易进展公告，2月4日股价上涨0.74%
证券之星 · 02-04
步长制药（603858）披露拟放弃优先受让控股子公司股权暨关联交易进展公告，2月4日股价上涨0.74%
步长制药（603858）披露以集中竞价交易方式首次回购股份公告，2月2日股价下跌0.94%
证券之星 · 02-02
步长制药（603858）披露以集中竞价交易方式首次回购股份公告，2月2日股价下跌0.94%
每周股票复盘：步长制药（603858）2025年净利预盈3.2亿至4.68亿元
证券之星 · 02-01
每周股票复盘：步长制药（603858）2025年净利预盈3.2亿至4.68亿元
步长制药最新公告：预计2025年净利润3.20亿元-4.68亿元同比扭亏为盈
证券之星 · 01-27
步长制药最新公告：预计2025年净利润3.20亿元-4.68亿元同比扭亏为盈
每周股票复盘：步长制药（603858）拟回购0.6亿至1.2亿元股份
证券之星 · 01-25
每周股票复盘：步长制药（603858）拟回购0.6亿至1.2亿元股份
步长制药（603858）披露以集中竞价交易方式回购股份计划，1月23日股价上涨1.23%
证券之星 · 01-23
步长制药（603858）披露以集中竞价交易方式回购股份计划，1月23日股价上涨1.23%
步长制药（603858）披露回购事项前十大股东持股情况，1月22日股价上涨0.94%
证券之星 · 01-22
步长制药（603858）披露回购事项前十大股东持股情况，1月22日股价上涨0.94%
步长制药为控股子公司上海合璞医疗科技提供5000万元担保
中金财经 · 01-22
步长制药为控股子公司上海合璞医疗科技提供5000万元担保
步长制药全资子公司山东丹红获准变更药品生产许可证，新增委托生产与批准文号
中金财经 · 01-22
步长制药全资子公司山东丹红获准变更药品生产许可证，新增委托生产与批准文号
每周股票复盘：步长制药（603858）拟回购0.6亿至1.2亿元股份
证券之星 · 01-18
每周股票复盘：步长制药（603858）拟回购0.6亿至1.2亿元股份
步长制药最新公告：拟以0.60亿元至1.20亿元回购股份用于股权激励等贷款不超1亿元
证券之星 · 01-16
步长制药最新公告：拟以0.60亿元至1.20亿元回购股份用于股权激励等贷款不超1亿元
步长制药转型之痛：6亿存货纠纷与3亿投资缩水背后的风险警示
新浪证券 · 01-16
步长制药转型之痛：6亿存货纠纷与3亿投资缩水背后的风险警示
步长制药陷存货危机：45亿库存压仓，5.5亿纠纷未解，销售费高企研发乏力
蓝鲸财经 · 01-07
步长制药陷存货危机：45亿库存压仓，5.5亿纠纷未解，销售费高企研发乏力
流感疫情持续，防控系统工程再受考验
证券之星 · 2025-12-31
流感疫情持续，防控系统工程再受考验
步长制药子公司起诉捷迈上海，涉库存纠纷金额超6.5亿元
中金财经 · 2025-12-30
步长制药子公司起诉捷迈上海，涉库存纠纷金额超6.5亿元
步长制药最新公告：控股子公司泸州步长与MEDISPEC签署《独家供应协议》
证券之星 · 2025-12-29
步长制药最新公告：控股子公司泸州步长与MEDISPEC签署《独家供应协议》
每周股票复盘：步长制药（603858）拟出资180万设互联网子公司
证券之星 · 2025-12-28
每周股票复盘：步长制药（603858）拟出资180万设互联网子公司
步长制药最新公告：控股子公司拟180万元对外投资设立子公司
证券之星 · 2025-12-24
步长制药最新公告：控股子公司拟180万元对外投资设立子公司
加载更多
公司概况
公司名称：
山东步长制药股份有限公司
所属行业：
医药制造业
上市日期：
2016-11-18
主营业务：
山东步长制药股份有限公司的主营业务是中成药的研发、生产和销售。公司的主要产品是脑心通胶囊、稳心颗粒、丹红注射液、康妇炎胶囊、红核妇洁洗液、前列舒通胶囊、宣肺败毒颗粒、复方脑肽节苷脂注射液、复方曲肽注射液、谷红注射液、银杏蜜环口服溶液、流感病毒裂解疫苗、A群C群脑膜炎球菌多糖疫苗、ACYW135群脑膜炎球菌多糖疫苗。公司名列“2023年度中国中药企业TOP100排行榜”第四位。
发行价格：
55.88
{"stockData":{"symbol":"603858","market":"SH","secType":"STK","nameCN":"步长制药","latestPrice":17.37,"timestamp":1770703629000,"preClose":17.37,"halted":0,"volume":4530813,"delay":0,"changeRate":0,"floatShares":1055000000,"shares":1055000000,"eps":0.0016,"marketStatus":"交易中","change":0,"latestTime":"02-10 14:07:09","open":17.31,"high":17.46,"low":17.17,"amount":78510400,"amplitude":0.0167,"askPrice":17.38,"askSize":40,"bidPrice":17.36,"bidSize":27,"shortable":0,"etf":0,"ttmEps":0.0016,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1770706800000},"marketStatusCode":2,"adr":0,"adjPreClose":17.37,"symbolType":"stock","openAndCloseTimeList":[[1770687000000,1770694200000],[1770699600000,1770706800000]],"highLimit":19.11,"lowLimit":15.63,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1054568442,"isCdr":false,"pbRate":1.73,"roa":"--","peRate":10856.25,"roe":"8.23%","epsLYR":-0.511,"committee":-0.078652,"marketValue":18318000000,"turnoverRate":0.0043,"status":2,"floatMarketCap":18318000000},"requestUrl":"/m/hq/s/603858","defaultTab":"news","newsList":[{"id":"2610177634","title":"步长制药84岁创始人被限高，赵氏家族资本版图扩张风波不断","url":"https://stock-news.laohu8.com/highlight/detail?id=2610177634","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610177634?lang=zh_cn&edition=full","pubTime":"2026-02-09 19:26","pubTimestamp":1770636399,"startTime":"0","endTime":"0","summary":"目前，宝石公司由赵步长直接持有49%的股份，吉林省安图长涛矿泉饮品有限公司持有51%的股份，其由赵涛的岳母王秀珍、赵涛的姐姐赵骅分别持股94.8%、1%，由赵氏家族实际控制。2024年，步长制药再次因计提商誉减值陷入亏损。1月29日，步长制药披露2025年业绩预告，因商誉减值计提同比减少公司扭亏为盈，全年净利润预计在3.2亿元至4.68亿元之间。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1770635549682440127","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["603858","BK0239","BK0196"],"gpt_icon":0},{"id":"2609525477","title":"每周股票复盘：步长制药（603858）首次回购股份217.6万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2609525477","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609525477?lang=zh_cn&edition=full","pubTime":"2026-02-08 02:15","pubTimestamp":1770488114,"startTime":"0","endTime":"0","summary":"截至2026年2月6日收盘，步长制药报收于17.38元，较上周的17.01元上涨2.18%。本周，步长制药2月6日盘中最高价报17.98元。公司公告汇总山东步长制药股份有限公司于2026年2月2日通过集中竞价交易方式首次回购股份2,176,000股，占公司总股本的0.21%。本次回购符合相关法律法规及公司回购方案要求。山东步长制药股份有限公司放弃控股子公司上海合璞医疗科技有限公司部分股权的优先受让权。交易完成后，公司仍持有上海合璞71.30%股权。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020800000656.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603858","BK0239","BK0196"],"gpt_icon":0},{"id":"2608605223","title":"步长制药（603858）披露拟放弃优先受让控股子公司股权暨关联交易进展公告，2月4日股价上涨0.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608605223","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608605223?lang=zh_cn&edition=full","pubTime":"2026-02-04 22:12","pubTimestamp":1770214344,"startTime":"0","endTime":"0","summary":"截至2026年2月4日收盘，步长制药报收于17.65元，较前一交易日上涨0.74%，最新总市值为186.13亿元。近日，山东步长制药股份有限公司发布《关于拟放弃优先受让控股子公司股权暨关联交易的进展公告》。公告显示，因业务发展需要，其控股子公司上海合璞医疗科技有限公司股东王宝才拟将其未实缴的0.05%股权转让给赵晓刚、0.025%股权转让给程锴，交易价格均为0元。交易完成后，公司仍持有上海合璞71.30%股权。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020400041291.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0196","603858"],"gpt_icon":0},{"id":"2608679548","title":"步长制药（603858）披露以集中竞价交易方式首次回购股份公告，2月2日股价下跌0.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608679548","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608679548?lang=zh_cn&edition=full","pubTime":"2026-02-02 22:19","pubTimestamp":1770041959,"startTime":"0","endTime":"0","summary":"截至2026年2月2日收盘，步长制药报收于16.85元，较前一交易日下跌0.94%，最新总市值为177.69亿元。近日，山东步长制药股份有限公司发布《关于以集中竞价交易方式首次回购股份的公告》。公告显示，公司于2026年2月2日通过集中竞价交易方式首次回购股份2,176,000股，占公司总股本的0.21%。本次回购符合相关法律法规及公司回购方案要求。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020200039237.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0196","603858"],"gpt_icon":0},{"id":"2608907725","title":"每周股票复盘：步长制药（603858）2025年净利预盈3.2亿至4.68亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2608907725","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608907725?lang=zh_cn&edition=full","pubTime":"2026-02-01 03:19","pubTimestamp":1769887150,"startTime":"0","endTime":"0","summary":"截至2026年1月30日收盘，步长制药报收于17.01元，较上周的17.34元下跌1.9%。本周，步长制药1月26日盘中最高价报17.6元。步长制药当前最新总市值179.38亿元，在中药板块市值排名13/67，在两市A股市值排名1189/5184。公司公告汇总：步长制药为控股子公司提供3,000万元连带责任担保，审批通过且风险可控。业绩披露要点步长制药发布业绩预告，预计2025年全年归属净利润盈利3.2亿元至4.68亿元，与上年同期相比实现扭亏为盈。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020100001101.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","BK0239","603858"],"gpt_icon":0},{"id":"2606204375","title":"步长制药最新公告：预计2025年净利润3.20亿元-4.68亿元同比扭亏为盈","url":"https://stock-news.laohu8.com/highlight/detail?id=2606204375","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606204375?lang=zh_cn&edition=full","pubTime":"2026-01-27 16:43","pubTimestamp":1769503431,"startTime":"0","endTime":"0","summary":"步长制药(603858.SH)公告称，预计2025年年度实现归属于上市公司股东的净利润约为3.20亿元到4.68亿元，与上年同期相比将实现扭亏为盈。业绩变动原因主要是本期商誉减值计提同比减少；药品销售规模同比增长；主要产品生产成本同比下降；收购标的评估增值摊销额同比减少。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012700027522.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603858"],"gpt_icon":0},{"id":"2606523273","title":"每周股票复盘：步长制药（603858）拟回购0.6亿至1.2亿元股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2606523273","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606523273?lang=zh_cn&edition=full","pubTime":"2026-01-25 03:12","pubTimestamp":1769281932,"startTime":"0","endTime":"0","summary":"截至2026年1月23日收盘，步长制药报收于17.34元，较上周的16.5元上涨5.09%。本周，步长制药1月23日盘中最高价报17.37元。截至公告日，公司及控股子公司对外担保总额为190,330.79万元，占最近一期经审计净资产的18.63%，无逾期担保。山东步长制药股份有限公司拟使用自有资金及金融机构专项借款，通过集中竞价交易方式回购股份，回购金额为0.60亿元至1.20亿元，价格不超过23.98元/股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012500001105.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603858","BK0239","BK0196"],"gpt_icon":0},{"id":"2605095164","title":"步长制药（603858）披露以集中竞价交易方式回购股份计划，1月23日股价上涨1.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605095164","media":"证券之星","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605095164?lang=zh_cn&edition=full","pubTime":"2026-01-23 23:03","pubTimestamp":1769180599,"startTime":"0","endTime":"0","summary":"截至2026年1月23日收盘，步长制药报收于17.34元，较前一交易日上涨1.23%，最新总市值为182.86亿元。该股当日开盘17.13元，最高17.37元，最低17.05元，成交额达1.13亿元，换手率为0.62%。近日，山东步长制药股份有限公司发布关于以集中竞价交易方式回购股份的回购报告书。公告显示，公司拟使用自有资金及金融机构专项借款，通过集中竞价交易方式回购股份，回购金额为0.60亿元至1.20亿元，价格不超过23.98元/股。回购期限为董事会审议通过之日起不超过十二个月。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012300043631.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0196","603858"],"gpt_icon":0},{"id":"2605949726","title":"步长制药（603858）披露回购事项前十大股东持股情况，1月22日股价上涨0.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605949726","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605949726?lang=zh_cn&edition=full","pubTime":"2026-01-22 22:35","pubTimestamp":1769092520,"startTime":"0","endTime":"0","summary":"截至2026年1月22日收盘，步长制药报收于17.13元，较前一交易日上涨0.94%，最新总市值为180.65亿元。该股当日开盘17.03元，最高17.19元，最低16.96元，成交额达8954.2万元，换手率为0.5%。根据相关规定，现披露董事会决议公告日前一交易日登记在册的前十大股东及前十大无限售条件股东的持股情况，包括股东名称、持股数量及占公司总股本比例。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012200041125.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603858","BK0196"],"gpt_icon":0},{"id":"2605434790","title":"步长制药为控股子公司上海合璞医疗科技提供5000万元担保","url":"https://stock-news.laohu8.com/highlight/detail?id=2605434790","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605434790?lang=zh_cn&edition=full","pubTime":"2026-01-22 08:10","pubTimestamp":1769040624,"startTime":"0","endTime":"0","summary":"中访网数据 山东步长制药股份有限公司于2026年1月19日发布公告，宣布为其控股子公司上海合璞医疗科技有限公司提供担保。根据公告，步长制药与广发银行股份有限公司上海分行签订了《最高额保证合同》，为上海合璞医疗科技与后者签订的《授信额度合同》提供总额为人民币5,000万元的连带责任保证担保。 截至本公告日，步长制药及其控股子公司对外担保总额累计约为19.03亿元，占公司2024年末经审计净资产的18.63%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20260122/31961806.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["603858","BK0239","159891","BK0196"],"gpt_icon":0},{"id":"2605434769","title":"步长制药全资子公司山东丹红获准变更药品生产许可证，新增委托生产与批准文号","url":"https://stock-news.laohu8.com/highlight/detail?id=2605434769","media":"中金财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605434769?lang=zh_cn&edition=full","pubTime":"2026-01-22 08:10","pubTimestamp":1769040624,"startTime":"0","endTime":"0","summary":"中访网数据 山东步长制药股份有限公司近日发布公告，其全资子公司山东丹红制药有限公司的《药品生产许可证》药品委托情况已获山东省药品监督管理局批准变更。公司表示，此次许可证变更有助于优化生产结构，保障稳定的生产能力以满足市场需求，预计将对公司未来经营产生积极影响。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20260122/31961805.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0196","BK0239","603858"],"gpt_icon":0},{"id":"2604925168","title":"每周股票复盘：步长制药（603858）拟回购0.6亿至1.2亿元股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2604925168","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604925168?lang=zh_cn&edition=full","pubTime":"2026-01-18 04:11","pubTimestamp":1768680667,"startTime":"0","endTime":"0","summary":"截至2026年1月16日收盘，步长制药报收于16.5元，较上周的16.58元下跌0.48%。本周，步长制药1月13日盘中最高价报16.95元。本周关注点公司公告汇总：步长制药拟以0.60亿元至1.20亿元回购股份，价格不超23.98元/股。转让完成后，陕西步长制药持股比例由56.50%增至86.50%，其他股东持股比例不变。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011800001251.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603858","BK0196","BK0239"],"gpt_icon":0},{"id":"2603613899","title":"步长制药最新公告：拟以0.60亿元至1.20亿元回购股份用于股权激励等贷款不超1亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2603613899","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603613899?lang=zh_cn&edition=full","pubTime":"2026-01-16 17:27","pubTimestamp":1768555657,"startTime":"0","endTime":"0","summary":"步长制药公告称，公司拟使用自有资金及金融机构回购专项借款，通过集中竞价交易方式回购社会公众股份，回购金额在0.60亿元至1.20亿元之间。回购股份将用于实施股权激励、员工持股计划以及转换上市公司发行的可转换为股票的公司债券。回购期限自董事会审议通过之日起不超过十二个月。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011600028230.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0196","603858"],"gpt_icon":0},{"id":"2603896919","title":"步长制药转型之痛：6亿存货纠纷与3亿投资缩水背后的风险警示","url":"https://stock-news.laohu8.com/highlight/detail?id=2603896919","media":"新浪证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603896919?lang=zh_cn&edition=full","pubTime":"2026-01-16 17:12","pubTimestamp":1768554720,"startTime":"0","endTime":"0","summary":"近期，步长制药在短短十天内接连发布两份公告，引发市场关注。先是控股子公司上海合璞因存货纠纷提起诉讼，涉及金额约6.52亿元；随后参股公司石榴云医在纳斯达克股价暴跌逾九成，导致公允价值预计损失约2.93亿元。这两起事件看似独立，实则共同折射出步长制药在从传统中药向生物药、医疗器械、互联网医疗全面转型过程中的深层风险。 步长制药旗下上海合璞与捷迈的存货纠纷，暴露了公司在医疗器械流通领域的战略短板。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/aigcy/2026-01-16/doc-inhhnzav3924778.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","BK0196","603858"],"gpt_icon":0},{"id":"2601875078","title":"步长制药陷存货危机：45亿库存压仓，5.5亿纠纷未解，销售费高企研发乏力","url":"https://stock-news.laohu8.com/highlight/detail?id=2601875078","media":"蓝鲸财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601875078?lang=zh_cn&edition=full","pubTime":"2026-01-07 17:19","pubTimestamp":1767777595,"startTime":"0","endTime":"0","summary":"此次案件涉案金额高达6.5189亿元人民币，其中库存价值约5.5亿元，利息及资金成本损失约9172.5万元。步长制药已在公告中进行了明确的风险提示，此次涉诉的5.5亿元左右存货存在计提存货跌价准备的风险。而值得注意的是，此次涉及诉讼只是步长制药整体存货的冰山一角，截至2025年三季度末，该公司存货已达45.17亿元，涉诉库存仅占总量的12%左右。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1767777433495411407","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["603858","BK0239","BK0196"],"gpt_icon":0},{"id":"2595127727","title":"流感疫情持续，防控系统工程再受考验","url":"https://stock-news.laohu8.com/highlight/detail?id=2595127727","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595127727?lang=zh_cn&edition=full","pubTime":"2025-12-31 17:18","pubTimestamp":1767172695,"startTime":"0","endTime":"0","summary":"2025年末，全国流感疫情持续处于高流行水平。产业链协同响应，构建多层次供应保障流感防控是一项系统工程，需要疫苗预防、快速诊断、药物治疗等多个环节的有效衔接。本轮疫情中，上市药企正通过全产业链布局，搭建从源头预防到终端治疗的健康保障网络。中成药在本轮疫情中表现活跃。公司表示，金振口服液四季度市场需求回暖，正加紧排产满足市场需要。随着该产品儿童流感新适应症的获批，其在儿科领域的应用场景进一步拓宽。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/SS2025123100030908.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0186","BK0077","000756","600557","002728","600079","BK0012","BK0236","002317","BK0096","002393","BK0197","BK0239","BK0097","002603","000999","BK0196","BK0074","BK0188","300937","BK0250","BK0175","603858","BK0086","BK0185","300244","603882","BK0042","SG9999001069.SGD","301207","600566","BK0046","BK0187","BK0060","BK0010","BK0164","BK0284","BK0070","BK0183","BK0201","BK0146","000623","BK0114","688276","BK0028"],"gpt_icon":0},{"id":"2595876825","title":"步长制药子公司起诉捷迈上海，涉库存纠纷金额超6.5亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2595876825","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595876825?lang=zh_cn&edition=full","pubTime":"2025-12-30 11:19","pubTimestamp":1767064752,"startTime":"0","endTime":"0","summary":"核心事件源于双方经销协议期满后，上海合璞持有的约5.5亿元捷迈供应产品库存未能按行业惯例顺利转移至新任授权经销商。上海合璞的诉讼请求包括：要求被告按约5.56亿元净价回购剩余库存、退还预付款约320万元，并支付利息损失等，合计金额暂计约6.52亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20251230/31902756.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0239","BK0196","603858"],"gpt_icon":0},{"id":"2595784366","title":"步长制药最新公告：控股子公司泸州步长与MEDISPEC签署《独家供应协议》","url":"https://stock-news.laohu8.com/highlight/detail?id=2595784366","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595784366?lang=zh_cn&edition=full","pubTime":"2025-12-29 18:50","pubTimestamp":1767005425,"startTime":"0","endTime":"0","summary":"步长制药(603858.SH)公告称，公司控股子公司泸州步长拟与马来西亚公司MEDISPEC签署《独家供应协议》，泸州步长授权MEDISPEC作为目标区域内独家代理商，在目标区域内完成注射用Efparepoetin alfa的注册、推广、分销及销售事宜。本次交易不构成关联交易，也不构成重大资产重组。本事项无需提交公司股东会审议批准。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122900026897.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603858","BK0239","BK0196"],"gpt_icon":0},{"id":"2594423582","title":"每周股票复盘：步长制药（603858）拟出资180万设互联网子公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2594423582","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594423582?lang=zh_cn&edition=full","pubTime":"2025-12-28 03:38","pubTimestamp":1766864292,"startTime":"0","endTime":"0","summary":"截至2025年12月26日收盘，步长制药报收于16.45元，较上周的16.36元上涨0.55%。山东步长制药股份有限公司控股子公司步长众鑫康医药拟出资180万元，与湖北合俊腾辉贸易有限公司共同设立步长互联网（湖北）有限公司，注册资本300万元，持股比例60%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122800000816.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","159792","160636","BK0239","603858"],"gpt_icon":0},{"id":"2593147919","title":"步长制药最新公告：控股子公司拟180万元对外投资设立子公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2593147919","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593147919?lang=zh_cn&edition=full","pubTime":"2025-12-24 19:00","pubTimestamp":1766574046,"startTime":"0","endTime":"0","summary":"步长制药(603858.SH)公告称，公司控股子公司步长众鑫康医药拟出资180万元，与湖北合俊腾辉贸易有限公司共同投资设立步长互联网（湖北）有限公司，注册资本为300万元，步长众鑫康医药持股比例为60%。该投资事项无需提交股东会审议，不会对公司本年度财务状况和经营成果造成重大影响，但从长远来看，将对公司持续经营能力和企业综合竞争力产生积极影响。新公司可能面临宏观政策调控、市场变化及经营管理等因素的影响，后续投资收益存在不确定性。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122400031587.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603858","BK0196"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1770703635199,"stockEarnings":[{"period":"1week","weight":0.0309},{"period":"1month","weight":0.0476},{"period":"3month","weight":-0.0164},{"period":"6month","weight":-0.0431},{"period":"1year","weight":0.1742},{"period":"ytd","weight":0.1106}],"compareEarnings":[{"period":"1week","weight":0.0267},{"period":"1month","weight":0.0006},{"period":"3month","weight":0.0301},{"period":"6month","weight":0.1194},{"period":"1year","weight":0.248},{"period":"ytd","weight":0.0389}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"山东步长制药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"51090人(较上一季度减少7.36%)","perCapita":"20641股","listingDate":"2016-11-18","address":"山东省菏泽市牡丹区中华西路369号","registeredCapital":"105456万元","survey":" 山东步长制药股份有限公司的主营业务是中成药的研发、生产和销售。公司的主要产品是脑心通胶囊、稳心颗粒、丹红注射液、康妇炎胶囊、红核妇洁洗液、前列舒通胶囊、宣肺败毒颗粒、复方脑肽节苷脂注射液、复方曲肽注射液、谷红注射液、银杏蜜环口服溶液、流感病毒裂解疫苗、A群C群脑膜炎球菌多糖疫苗、ACYW135群脑膜炎球菌多糖疫苗。公司名列“2023年度中国中药企业TOP100排行榜”第四位。","listedPrice":55.88},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"步长制药(603858)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供步长制药(603858)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"步长制药,603858,步长制药股票,步长制药股票老虎,步长制药股票老虎国际,步长制药行情,步长制药股票行情,步长制药股价,步长制药股市,步长制药股票价格,步长制药股票交易,步长制药股票购买,步长制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"步长制药(603858)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供步长制药(603858)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}